Assembly Biosciences Inc
$ 26.68
0.87%
07 Aug - close price
- Market Cap 524,166,000 USD
- Current Price $ 26.68
- High / Low $ 27.12 / 26.36
- Stock P/E 330.62
- Book Value 12.50
- EPS 0.08
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.05 %
- ROE -0.06 %
- 52 Week High 39.71
- 52 Week Low 20.23
About
Assembly Biosciences, Inc. is a clinical-stage biotechnology company in the United States. The company is headquartered in South San Francisco, California.
Analyst Target Price
$50.00
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ASMB
2026-08-04 09:24:00
This article analyzes Assembly Biosciences Inc. (NASDAQ: ASMB), highlighting a weak near and mid-term sentiment but a neutral long-term outlook. It identifies a mid-channel oscillation pattern and an exceptional short setup targeting an 18.0% downside with minimal risk. The analysis also provides institutional trading strategies for long, breakout, and short positions based on AI models, alongside multi-timeframe signal analysis.
2026-07-30 04:49:47
Assembly Biosciences Inc (ASMB) has an institutional shareholding score of 5.00, placing it 132nd out of 384 in the Biotechnology & Medical Research industry. The institutional shareholding proportion is 58.24%, marking a 171.06% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 348.54K shares, which represents 2.17% of shares outstanding.
2026-07-29 06:12:25
Assembly Biosciences Inc (ASMB) has a risk assessment score of 4.63, placing it 69th out of 385 in the Biotechnology & Medical Research industry. The company's beta of 1.09 indicates higher volatility compared to the S&P 500 index. The article details various risk metrics including maximum drawdown, volatility, Sharpe ratio, and liquidity measures over different periods.
2026-07-27 09:41:09
This article provides an overview of Assembly Biosciences Inc (ASMB) dividends and stock splits. It notes that no dividends have been distributed in the past five years and lists several merger-related stock split events that occurred on February 8, 2024, with a 12-to-1 ratio.
2026-07-27 07:11:03
This article provides a detailed cash flow statement for Assembly Biosciences Inc (ASMB), including operating, investing, and financing cash flows presented quarterly and annually. It features historical financial data stretching back to 2012, along with year-over-year percentage changes. The article also includes FAQs explaining key cash flow metrics like operating cash flow, investing cash flow, financing cash flow, and free cash flow, and applies these definitions to ASMB's recent performance.
2026-07-27 00:40:44
The article provides an overview of market sentiment signals for Assembly Biosciences (ASMB), including analyst consensus, short interest, options flow, and recent analyst actions. It highlights a "Buy" consensus from analysts with an average price target significantly above the current stock price, increasing short interest, and bullish options flow. The piece also details various analyst ratings and price target changes from firms like Mizuho, Guggenheim, HC Wainwright & Co., and Jefferies.
